Xuan Quynh LLC Joins PHILUX Global Funds to Participate in Luxembourg-based Infrastructure Fund for Vietnam and Laos Other OTC:PHIL

[ad_1] New York, Nov. 29, 2020 (GLOBE NEWSWIRE) — PHI Group, Inc. (www.phiglobal.com, PHIL), announced today that Xuan Quynh Limited Liability Company, a Vietnamese infrastructure construction and development company, has signed an agreement with PHI Luxembourg Development SA, the mother holding company for PHILUX Global Funds SCA, SICAV-RAIF, to join its “PHILUX Infrastructure Fund” compartment as … Read moreXuan Quynh LLC Joins PHILUX Global Funds to Participate in Luxembourg-based Infrastructure Fund for Vietnam and Laos Other OTC:PHIL

Sorrento to Participate in the 32nd Piper Sandler Healthcare Investor Conference Nasdaq:SRNE

[ad_1] SAN DIEGO, Nov. 29, 2020 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (NASDAQ: SRNE, “Sorrento”), is pleased to announce that Dr. Henry Ji, Chairman and CEO, will be participating in the Piper Sandler 32nd Annual Virtual Healthcare Conference. A pre-recorded presentation is made available to participants and the public, in addition to 1 on 1 … Read moreSorrento to Participate in the 32nd Piper Sandler Healthcare Investor Conference Nasdaq:SRNE

AutoZone to Release First Quarter Earnings December 8, 2020 NYSE:AZO

[ad_1] MEMPHIS, Tenn., Nov. 27, 2020 (GLOBE NEWSWIRE) — AutoZone, Inc. (NYSE:AZO), the nation’s leading auto parts retailer and a leading distributor of automotive replacement parts and accessories, will release results for its first quarter ended Saturday, November 21, 2020, before market open on Tuesday, December 8, 2020. Additionally, the Company will host a one-hour … Read moreAutoZone to Release First Quarter Earnings December 8, 2020 NYSE:AZO

IBC Advanced Alloys Announces Closing of $1,400,000 Funding by Lind Partners TSX Venture Exchange:IB

[ad_1] [NOT FOR DISTRIBUTION TO U.S. NEWSWIRES OR FOR DISSEMINATION IN THE UNITED STATES] FRANKLIN, Ind., Nov. 27, 2020 (GLOBE NEWSWIRE) — IBC Advanced Alloys Corp. (“IBC” or the “Company”) (TSX-V: IB; OTCQB: IAALF) announced that it has closed on a second funding under the previously announced convertible security funding agreement (the “Agreement”) with Lind … Read moreIBC Advanced Alloys Announces Closing of $1,400,000 Funding by Lind Partners TSX Venture Exchange:IB

Advaxis, Inc. Announces Closing of $9.2 Million Public Offering Nasdaq:ADXS

[ad_1] PRINCETON, N.J., Nov. 27, 2020 (GLOBE NEWSWIRE) — Advaxis, Inc. (Nasdaq: ADXS) (the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today announced the closing of an underwritten public offering of 26,666,666 shares of common stock and warrants to purchase up to 13,333,333 shares of common stock, along … Read moreAdvaxis, Inc. Announces Closing of $9.2 Million Public Offering Nasdaq:ADXS

DATA443 TRIPLES DATA CENTER STORAGE CAPACITY DUE TO SIGNIFICANT INCREASE IN CUSTOMER CONSUMPTION OTC Markets:ATDS

[ad_1] Customer Reliance and Trust in Data443 Capabilities, Including Privacy and Security Capability for Data Storage and Processing, Increasing Exponentially RESEARCH TRIANGLE PARK, NC, Nov. 27, 2020 (GLOBE NEWSWIRE) — Data443 Risk Mitigation, Inc. (“Data443” or the “Company”) (OTCPK: ATDS), a leading data security and privacy software company for ALL THINGS DATA SECURITY™, announced several … Read moreDATA443 TRIPLES DATA CENTER STORAGE CAPACITY DUE TO SIGNIFICANT INCREASE IN CUSTOMER CONSUMPTION OTC Markets:ATDS

L Brands to Present at the Morgan Stanley 2020 Virtual Global Consumer & Retail Conference NYSE:LB

[ad_1] COLUMBUS, Ohio, Nov. 27, 2020 (GLOBE NEWSWIRE) — L Brands, Inc. (NYSE: LB) is scheduled to participate in the Morgan Stanley 2020 Virtual Global Consumer & Retail Conference on Dec. 2, 2020. Andrew Meslow, Chief Executive Officer of L Brands and Bath & Body Works, will be presenting at 1:00 p.m. Eastern. A link … Read moreL Brands to Present at the Morgan Stanley 2020 Virtual Global Consumer & Retail Conference NYSE:LB

USAN Modifies Lead Drug Candidate’s Chemical Name to ‘Simufilam’ Nasdaq:SAVA

[ad_1] AUSTIN, Texas, Nov. 27, 2020 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA) today announced that the World Health Organization (WHO) advised the United States Adopted Names Council (USAN) to modify the chemical name of the Company’s lead drug candidate to ‘simufilam.’ This change was advised by WHO to avoid a potential trademark conflict … Read moreUSAN Modifies Lead Drug Candidate’s Chemical Name to ‘Simufilam’ Nasdaq:SAVA

DARPA and JPEO Award Contract to SmartPharm, a Subsidiary of Sorrento, for Development of Rapid Countermeasure Against COVID-19 Using Gene-Encoded Neutralizing Antibodies

[ad_1] Initial funding of up to $34 million for the project “Gene Mabs: A Scalable, Economic, Gene-Encoded Protective Antibody Platform Against Coronavirus” (HR0011-21-9-0015) to support the development of an STI-2020-encoded Gene MAbTM through Phase 2 clinical studies. STI-2020-encoded Gene MAb is in development for intramuscular injection against the SARS-CoV-2 virus and its variant strains to … Read moreDARPA and JPEO Award Contract to SmartPharm, a Subsidiary of Sorrento, for Development of Rapid Countermeasure Against COVID-19 Using Gene-Encoded Neutralizing Antibodies

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE™ (setmelanotide) as First-ever Therapy for Chronic Weight Management in Patients with Obesity Due to POMC, PCSK1 or LEPR Deficiency

[ad_1] IMCIVREE™(setmelanotide) Logo Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE™(setmelanotide) as First-ever Therapy for Chronic Weight Management in Patients with Obesity Due to POMC, PCSK1 or LEPR Deficiency — Indicated for chronic weight management in adult and pediatric patients 6 years of age and older with obesity due to POMC, PCSK1 or LEPR deficiency confirmed … Read moreRhythm Pharmaceuticals Announces FDA Approval of IMCIVREE™ (setmelanotide) as First-ever Therapy for Chronic Weight Management in Patients with Obesity Due to POMC, PCSK1 or LEPR Deficiency